AU631204B2 - Use of monoacyl phosphoglycerides to enhance the corneal penetration of ophthalmic drugs - Google Patents

Use of monoacyl phosphoglycerides to enhance the corneal penetration of ophthalmic drugs

Info

Publication number
AU631204B2
AU631204B2 AU54030/90A AU5403090A AU631204B2 AU 631204 B2 AU631204 B2 AU 631204B2 AU 54030/90 A AU54030/90 A AU 54030/90A AU 5403090 A AU5403090 A AU 5403090A AU 631204 B2 AU631204 B2 AU 631204B2
Authority
AU
Australia
Prior art keywords
composition
monoacyl
lysolecithin
phosphoglyceride
drug
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
AU54030/90A
Other languages
English (en)
Other versions
AU5403090A (en
Inventor
Eugene R. Cooper
Douglas F. Hager
Tai-Lee Ke
Jamieson Charles Keister
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Alcon Vision LLC
Original Assignee
Alcon Laboratories Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Alcon Laboratories Inc filed Critical Alcon Laboratories Inc
Publication of AU5403090A publication Critical patent/AU5403090A/en
Application granted granted Critical
Publication of AU631204B2 publication Critical patent/AU631204B2/en
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0048—Eye, e.g. artificial tears
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/24—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing atoms other than carbon, hydrogen, oxygen, halogen, nitrogen or sulfur, e.g. cyclomethicone or phospholipids

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Public Health (AREA)
  • Ophthalmology & Optometry (AREA)
  • Biophysics (AREA)
  • Molecular Biology (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
AU54030/90A 1989-03-29 1990-03-28 Use of monoacyl phosphoglycerides to enhance the corneal penetration of ophthalmic drugs Expired - Fee Related AU631204B2 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US329924 1988-03-29
US32992489A 1989-03-29 1989-03-29

Publications (2)

Publication Number Publication Date
AU5403090A AU5403090A (en) 1990-10-22
AU631204B2 true AU631204B2 (en) 1992-11-19

Family

ID=23287604

Family Applications (1)

Application Number Title Priority Date Filing Date
AU54030/90A Expired - Fee Related AU631204B2 (en) 1989-03-29 1990-03-28 Use of monoacyl phosphoglycerides to enhance the corneal penetration of ophthalmic drugs

Country Status (7)

Country Link
EP (1) EP0465580A4 (xx)
JP (1) JPH04504258A (xx)
AU (1) AU631204B2 (xx)
CA (1) CA2013225A1 (xx)
IL (1) IL93925A0 (xx)
WO (1) WO1990011079A1 (xx)
ZA (1) ZA902442B (xx)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5109118A (en) * 1989-07-06 1992-04-28 Yutaka Mizushima Modified biologically active proteins
FR2673513B1 (fr) * 1991-03-05 1993-10-29 Institut Recherche Biologique Sa Nouvelles compositions dietetiques a base de lipides phosphoryles et leur utilisation dans l'amelioration des troubles de la vision.
WO1999009037A1 (de) 1997-08-18 1999-02-25 MAX-PLANCK-Gesellschaft zur Förderung der Wissenschaften e.V. Phospholipidanaloge verbindungen
EP2574341B1 (en) 2004-03-29 2017-03-29 University Of South Florida Effective treatment of tumors and cancer with triciribine phosphate
JP5670200B2 (ja) * 2008-12-02 2015-02-18 ロート製薬株式会社 眼科用組成物
US12042500B2 (en) * 2018-04-03 2024-07-23 Hyderabad Eye Research Foundation Mucoadhesive drug delivery system for ocular administration of fluoroquinolone antibiotics

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS62270521A (ja) * 1986-05-16 1987-11-24 Green Cross Corp:The フルルビプロフエン眼投与製剤
GB8712176D0 (en) * 1987-05-22 1987-06-24 Cosmas Damian Ltd Drug delivery system

Also Published As

Publication number Publication date
IL93925A0 (en) 1990-12-23
ZA902442B (en) 1991-01-30
JPH04504258A (ja) 1992-07-30
EP0465580A1 (en) 1992-01-15
CA2013225A1 (en) 1990-09-29
AU5403090A (en) 1990-10-22
EP0465580A4 (en) 1992-03-18
WO1990011079A1 (en) 1990-10-04

Similar Documents

Publication Publication Date Title
US5221696A (en) Use of monoacyl phosphoglycerides to enhance the corneal penetration of ophthalmic drugs
EP0845268B1 (en) Use of SCF for treating cornea
CA2423354C (en) Self-preserved nasal, inhalable, and topical ophthalmic preparations and medications
EP1553953B1 (en) Method and composition containing latanoprost for treating ocular hypertension and glaucoma
US5283236A (en) Systemic delivery of polypeptides through the eye
US6630135B1 (en) Use of sustained release antibiotic compositions in ophthalmic surgical procedures
US20190070176A1 (en) Method of increasing bioavailability and/or prolonging ophthalmic action of a drug
US20030185892A1 (en) Intraocular delivery compositions and methods
US20120264681A1 (en) Buffered ophthalmic compositions and methods of use thereof
KR101560429B1 (ko) 눈의 통증을 치료 또는 예방하기 위한 케토롤락 트로메타민 조성물
SK119895A3 (en) Pharmaceutical composition containing lipophilic drugs
US5278142A (en) Systemic delivery of polypeptides through the eye
Phinney et al. Corneal edema related to accidental Hibiclens exposure
JPH0723325B2 (ja) 眼病用製剤
AU631204B2 (en) Use of monoacyl phosphoglycerides to enhance the corneal penetration of ophthalmic drugs
EP0655911B1 (en) Ophthalmological preparation
EP0444778A1 (en) Use of alkyl saccharides to enhance the penetration of drugs
JPH03133936A (ja) 蛋白質ゲル状眼用賦形剤
JPH08503969A (ja) 増殖因子と組織形成抑制剤を含有する組成物
Palmer et al. Tear film, pharmacology of eye drops, and toxicity
US20210128458A1 (en) Ophthalmic compositions containing a nitric oxide releasing prostamide
WO1999022715A1 (en) Sustained release eyedrops
CZ294314B6 (cs) Topické oftalmické léčivo
RU2434633C2 (ru) Фармацевтические препаративные формы латрункулина
WO2006043172A1 (en) Pharmaceutical compositions and methods for sub-tenon delivery